2023 Ludvik B, Giorgino F, Jodar E et al (2021) Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Through this dual-receptor mechanism, tirzepatide exerts more potent actions on glycemic regulation, appetite suppression, and energy balance than conventional single-pathway GLP-1 receptor agonists
Monotherapy is reasonable for an initial cycle to establish tolerability
They have patterns of damage across multiple joints and soft tissue areas that a single injection site cannot address
Estrogen receptors and endometriosis
In particular, functions of all GST members including Lambda class GSTs need to be explored because of its importance in As stress response